CEL-SCI Corp Files Preliminary Proxy Statement
Ticker: CVM · Form: DEF 14A · Filed: Apr 9, 2025 · CIK: 725363
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: CVM
TL;DR
CVM filed preliminary proxy docs for annual meeting - expect definitive statement soon.
AI Summary
CEL-SCI CORPORATION (NYSE: CVM) filed a preliminary proxy statement on April 9, 2025, for its annual meeting. The filing indicates that the company is seeking shareholder approval for various matters, including the election of directors and the ratification of its independent registered public accounting firm. Specific details regarding the proposals and the meeting date are expected in the definitive proxy statement.
Why It Matters
This filing is a routine step before the company's annual shareholder meeting, where key corporate decisions are made and leadership is elected.
Risk Assessment
Risk Level: low — This is a standard preliminary filing for an upcoming shareholder meeting and does not contain new financial or operational information that would immediately impact the stock price.
Key Players & Entities
- CEL-SCI CORPORATION (company) — Registrant
- CVM (company) — Ticker Symbol
- April 9, 2025 (date) — Filing Date
FAQ
What is the purpose of this DEF 14A filing?
This filing is a preliminary proxy statement filed by CEL-SCI CORPORATION in advance of its annual shareholder meeting, outlining matters to be voted upon by shareholders.
When was this preliminary proxy statement filed?
The preliminary proxy statement was filed on April 9, 2025.
What are the typical items included in a DEF 14A filing like this?
DEF 14A filings typically include information about the election of directors, executive compensation, ratification of independent auditors, and other shareholder proposals.
Where is CEL-SCI CORPORATION headquartered?
CEL-SCI CORPORATION is headquartered in Vienna, VA.
What is the SIC code for CEL-SCI CORPORATION?
The Standard Industrial Classification (SIC) code for CEL-SCI CORPORATION is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 9, 2025 regarding CEL SCI CORP (CVM).